CST3 and chronic kidney disease: Baseline interleukin 6 (IL-6) was inversely associated with change in eGFRcreat over 12 months in the non-CKD group, and in the pre-existing CKD group and cystatin-C was inversely associated with CKD progression in the non-CKD group only.